Evidence-based emergency medicine/systematic review abstract. Use of low molecular weight heparins in patients with acute venous thromboembolism.
Rowe
Brian H
BH
Division of Emergency Medicine University of Alberta, Edmonton, Alberta, Canada. brian.rowe@ualberta.ca
Lang
Eddy S
ES
D000328:Adult; D006801:Humans; D000925:Anticoagulants / Q000008:administration & dosage / Q000009:adverse effects / Q000627:therapeutic use; D002986:Clinical Trials as Topic; D016001:Confidence Intervals; D004635:Emergency Medicine; D019317:Evidence-Based Medicine; D005343:Fibrinolytic Agents / Q000008:administration & dosage / Q000009:adverse effects / Q000627:therapeutic use; D005500:Follow-Up Studies; D006493:Heparin / Q000627:therapeutic use; D006495:Heparin, Low-Molecular-Weight / Q000008:administration & dosage / Q000009:adverse effects / Q000627:therapeutic use; D016017:Odds Ratio; D017410:Practice Guidelines as Topic; D011655:Pulmonary Embolism / Q000188:drug therapy; D013923:Thromboembolism / Q000188:drug therapy; D013997:Time Factors; D020246:Venous Thrombosis / Q000188:drug therapy; D000078202:Systematic Reviews as Topic
D000925:Anticoagulants; D005343:Fibrinolytic Agents; D006493:Heparin; D006495:Heparin, Low-Molecular-Weight